Nephros (NEPH) Corporate presentation summary

Business overview and market position

• Provides advanced water filtration solutions for healthcare, hospitality, institutions, government, and manufacturing sectors, with FDA-cleared Class II products for infection control and dialysis applications.

• Proprietary hollow-fiber membrane technology enables effective retention of bacteria, viruses, endotoxins, and nano- and microplastics.

• Recurring revenue model driven by programmatic replacement orders and strong regulatory tailwinds from ASHRAE, AAMI, and other standards.

• No debt and a strong balance sheet support ongoing growth initiatives.

Leadership and governance

• New executive team with proven track records in innovation, financial leadership, and strategic growth.

• Board includes experienced professionals from finance, healthcare, and operations backgrounds.

Product segments and technology

• Two main business lines: medical water filtration (infection control and dialysis) and commercial water filtration.

• Medical filters are FDA 510(k)-cleared, offering sub-micron purification and long filter life for infection control and dialysis.

• Commercial filters reduce contaminants like lead, PFAS, and scale, improving equipment performance and efficiency.